Background: The Cardiff Acne Disability Index (CADI) evaluates the impact of acne on the patient's life.
Objective: The objective of the present study was to translate the CADI into French and to validate the French version.
Method: The CADI was translated into French following international methodological recommendations (translation, quality control, back-translation and pilot test).
Results: Compatibility difficulties between the cultural background of UK and France were identified and resolved by the translation process, which should guarantee that specific words and phrases reflect the cultures in the respective countries. A pilot test in volunteers demonstrated the clarity and understandability of the questions across social classes and ages. A preliminary test-retest comparison of the final scale showed sufficient reliability, with a correlation coefficient of 0.90 for the total CADI score of the French version. Moreover, the good internal consistency of the scale was demonstrated with a Cronbach alpha of 0.87.
Conclusion: The CADI, a valuable tool for assessing the impact of acne on a patient's life, can now be used in French.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000076481 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment.
J Eur Acad Dermatol Venereol
December 2024
European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.
Introduction: This second part of the S2k guidelines is an update of the 2015 S1 European guidelines.
Objective: These guidelines aim to provide an accepted decision aid for the selection, implementation and assessment of appropriate and sufficient therapy for patients with hidradenitis suppurativa/acne inversa (HS).
Methods: The chapters have been selected after a Delphi procedure among the experts/authors.
Illness acceptance among young adults with acne: a cross-sectional study.
Postepy Dermatol Alergol
October 2024
Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Article Synopsis
- * It involved 213 individuals with varying acne severities, using questionnaires to assess illness acceptance, quality of life, and stigmatization.
- * Results showed that higher illness acceptance was associated with lower acne severity and better quality of life, suggesting that improving acceptance could enhance patients' psychological well-being.
Impact of Acne on the Quality of Life of Adolescents in the Territory of the Northern and Southern Regions of Montenegro.
Iran J Public Health
October 2024
Primary Health Care Center, Niksic, Montenegro.
Background: Acne vulgaris is a chronic inflammatory disease predominantly known as a disease of adolescents. We aimed to assess the quality of life of adolescents with acne in the territory of northern and southern regions of Montenegro.
Methods: This cross-sectional study was conducted in 2024, in four secondary schools in the north and south of Montenegro with total number of 561 subjects.
Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe.
Int J Dermatol
November 2024
Aragon Psychodermatology Research Group Zaragoza, Zaragoza, Spain.
Article Synopsis
- Hidradenitis suppurativa (HS) can greatly impact patients' quality of life due to its association with psychological issues like anxiety and depression, often intensified by stigmatization related to physical appearance.
- A study involving 135 HS patients from 22 dermatology clinics in Europe found significant levels of perceived stigmatization, which correlated with disease duration, itchiness, and depression symptoms.
- The research emphasizes the need for comprehensive management of HS, including addressing psychological well-being and access to mental health support for better patient outcomes.
Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USA.
Dermatology
November 2024
Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School and Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Boston, Massachusetts, USA.
Introduction: Hidradenitis suppurativa (HS) is a debilitating, inflammatory skin disorder. Treatment strategies in patients with HS are challenging; real-world evidence in a HS population is warranted for greater disease understanding. The objective of this analysis was to describe real-world treatment patterns and treatment satisfaction in patients with HS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!